Adamson (2010). "Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or Ph III Ewing’s Sarcoma Vigil ± Irinotecan +Temozolomide IND 014205 CL-PTL-130 Version: 03 Page 74 of 74 Confidential and proprietary information of Gradalis, Inc. Effective: 05-DEC-2018 It is the user’s responsibility to verify adequate training before executing a document. Do not make unauthorized copies. refractory solid tumors: a Children's Oncology Group phase I consortium study." Pediatr Blood Canc er 54(4): 538-545. 69. Wheler, J., A. M. Tsimberidou, D. Hong, A. Naing, G. Falchook, S. Piha-Paul, S. Fu, S. Moulder, B. Stephen, S. Wen and R. Kurzrock (2012). "Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience." Clin Cancer Res 18(10): 2922-2929. 70. Yildiz, I., F. Sen, M. Ekenel, E. Darendeliler, S. Bavbek, F. Agaoglu, H. Ozger, L. Eralp, B. Bilgic and M. Basaran (2014). "Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey." In Vivo 28(3): 403-409.